
CAS Number142706-18-1
Synonyms2-({[3,4-bis(methyloxy)pyridin-2-yl]methyl}sulfinyl)-6-[(difluoromethyl)oxy]-1H-benzimidazole; ((R)-6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole); 6-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 5-(Difluoromethoxy)-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl}-1H-benzimidazole; UNII:D8TST4O562; 5-(Difluormethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazol
Molecular FormulaC16H15F2N3O4S
Molecular Weight383.370
Density1.5±0.1 g/cm3
Boiling Point586.9±60.0 °C at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 142706-18-1 |
| Catalog No. | 2A-3180351 |
| Chinese Name | 左旋泮托拉唑 |
| Synonyms | 2-({[3,4-bis(methyloxy)pyridin-2-yl]methyl}sulfinyl)-6-[(difluoromethyl)oxy]-1H-benzimidazole; ((R)-6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole); 6-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 5-(Difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 5-(Difluoromethoxy)-2-{[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl}-1H-benzimidazole; UNII:D8TST4O562; 5-(Difluormethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazol |
| Molecular Formula | C16H15F2N3O4S |
| Molecular Weight | 383.370 |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 586.9±60.0 °C at 760 mmHg |
| PubChem ID | 42261691 |
| SMILES | COc1ccnc(CS(=O)c2nc3ccc(OC(F)F)cc3[nH]2)c1OC |
| InChI | InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)/t26-/m1/s1 |
| InChI Key | IQPSEEYGBUAQFF-AREMUKBSSA-N |
| Transport Info | Product Name: (R)-(+)-Pantoprazole |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| O-Desmethyl Gefitinib | 847949-49-9 | 2A-3180339 |
| 3-DesMorpholinyl-3-hydroxyethylaMino Gefitinib | 847949-56-8 | 2A-3180340 |
| 4-Defluoro-4-hydroxy Gefitinib | 847949-50-2 | 2A-3180344 |
| Linagliptin N-Acetyl Impurity | 1803079-49-3 | 2A-3180345 |
| N-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl Lansoprazole | 1083100-26-8 | 2A-3180348 |
| S-Pantoprazole | 142678-35-1 | 2A-3180352 |
| Sorafenib related coMpound 4 | 1129683-83-5 | 2A-3180356 |
| Sorafenib Related Compound B | 2004659-84-9 | 2A-3180357 |
| Sorafenib related compound 12 | 284461-74-1 | 2A-3180358 |
| Tadalafil impurity | 185750-07-6 | 2A-3180380 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA